| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2021―Jun―25 |
Editorial: IBD medications during the COVID-19 pandemic-are they safe to use? |
Dali Fan, Richard B. Gearry |
| 2 |
[GO] |
2021―Jun―10 |
Risk of severe COVID-19 in patients treated with IBD medications: a French nationwide study |
Antoine Meyer, Laura Semenzato, Mahmoud Zureik, Alain Weill, Franck Carbonnel, Rosemary Dray-Spira |
| 3 |
[GO] |
2020―Oct―07 |
Letter: population mortality from COVID-19 and latitude-data from China |
Nanyang Liu, Hao Li |
| 4 |
[GO] |
2020―Aug―31 |
Systematic review with meta-analysis: SARS-CoV-2 stool testing and the potential for faecal-oral transmission |
Amarylle S. van Doorn, Berrie Meijer, Chris M. A. Frampton, Murray L. Barclay, Nanne K. H. de Boer |
| 5 |
[GO] |
2020―Aug―15 |
Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with COVID-19 |
Gianluca Ianiro, Serena Porcari, Carlo Romano Settanni, Stefano Bibbò, Francesca Romana Ponziani, Lorenzo Zileri dal Verme, et al. (+3) Francesco Franceschi, Giovanni Cammarota, Antonio Gasbarrini |
| 6 |
[GO] |
2020―Aug―15 |
Letter: online search trends suggest patient concerns around immunosuppression use in inflammatory bowel disease during COVID-19 in the United Kingdom |
Mohammed Nabil Quraishi, Jonathan P. Segal, Rachel Cooney, Nicholas A. Kennedy, Rachel Ainley, Naveen Sharma, et al. (+2) Neeraj B. Bhala, Matthew J. Brookes |
| 7 |
[GO] |
2020―Aug―15 |
Letter: role of probiotics in the COVID-19 pandemic |
Enrik John T. Aguila, Marie Antoinette D. C. Lontok, Eliezer James T. Aguila |
| 8 |
[GO] |
2020―Aug―15 |
Letter: role of probiotics in the COVID-19 pandemic-authors' reply |
Yuan Tian, Long Rong |
| 9 |
[GO] |
2020―Aug―15 |
Letter: is pneumococcal vaccination safe during the COVID-19 pandemic? |
Rabia Deniz, Arif Atahan Çağatay, Ahmet Gül |
| 10 |
[GO] |
2020―Aug―15 |
Letter: is pneumococcal vaccination safe during the COVID-19 pandemic? Authors’ reply |
Aysha H. Al-Ani, Doug Johnson, Britt Christensen |
| 11 |
[GO] |
2020―Aug―15 |
Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with coronavirus disease 2019-authors' reply |
Yuan Tian, Long Rong |
| 12 |
[GO] |
2020―Aug―15 |
Letter: immunotherapy in IBD patients in a SARS-CoV-2 endemic area |
Constanze H. Waggershauser, Cornelia Tillack-Schreiber, Christine Berchtold-Benchieb, Daniel Szokodi, Stefanie Howaldt, Thomas Ochsenkühn |
| 13 |
[GO] |
2020―Aug―15 |
Letter: immunotherapy for IBD patients in a SARS-CoV-2 endemic area-authors' reply |
Carlos Taxonera, Iñigo Sagastagoitia, Cristina Alba |
| 14 |
[GO] |
2020―Aug―10 |
Editorial: social distancing during the COVID-19 pandemic - IBD patients cannot stay at home forever |
Samantha Jane Benson-Pope, Richard B. Gearry |
| 15 |
[GO] |
2020―Aug―10 |
Editorial: social distancing during the COVID-19 pandemic-IBD patients cannot stay at home forever. Authors' reply |
Carlos Taxonera, Cristina Alba |
| 16 |
[GO] |
2020―Aug―10 |
Letter: IBD nurse-a pivotal role in the time of the pandemic |
Muhammad Umair Khan, Kamran Mushtaq, Khalid Mohsin A. A. Al-Ejji, Rafie A. Yakoob, Saad Rashid Alkaabi, Masoud Khoshnia |
| 17 |
[GO] |
2020―Aug―10 |
Letter: IBD nurse-pivotal role in the time of the pandemic. Authors’ reply |
Aysha H. Al-Ani, Clarissa A. Rentsch, Sofia Azim, Emma Bidgood, Princy Onasseril, Britt Christensen |
| 18 |
[GO] |
2020―Jul―22 |
The association between markers of liver injury and clinical outcomes in patients with COVID-19 in Wuhan |
Haijun Huang, Shanshan Chen, Hong Li, Xian-Long Zhou, Yining Dai, Wu Jia, et al. (+7) Jun Zhang, Lina Shao, Rong Yan, Mingshan Wang, Jiafeng Wang, Yuexing Tu, Minghua Ge |
| 19 |
[GO] |
2020―Jul―13 |
Letter: ACE2, Rho kinase inhibition and the potential role of vitamin D against COVID-19 |
Giovanni Bertoldi, Lisa Gianesello, Lorenzo A. Calò |
| 20 |
[GO] |
2020―Jul―13 |
Letter: liver disease and COVID-19-not the perfect storm |
Rooshi Nathwani, Sujit Mukherjee, Roberta Forlano, Benjamin H. Mullish, Nikhil Vergis, Nowlan Selvapatt, et al. (+4) Pinelopi Manousou, Shevanthi Nayagam, Maud Lemoine, Ameet Dhar |
| 21 |
[GO] |
2020―Jul―13 |
Letter: liver disease and COVID-19-not the perfect storm. Authors' reply” |
Isabel Garrido, Rodrigo Liberal, Guilherme Macedo |
| 22 |
[GO] |
2020―Jul―08 |
Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19 |
Anand V. Kulkarni, Pramod Kumar, Harsh Vardhan Tevethia, Madhumita Premkumar, Juan Pablo Arab, Roberto Candia, et al. (+5) Rupjyoti Talukdar, Mithun Sharma, Xiaolong Qi, Padaki Nagaraja Rao, Duvvuru Nageshwar Reddy |
| 23 |
[GO] |
2020―Jul―06 |
Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2 positive patients |
Francesca Romana Ponziani, Fabio Del Zompo, Antonio Nesci, Francesco Santopaolo, Gianluca Ianiro, Maurizio Pompili, Antonio Gasbarrini |
| 24 |
[GO] |
2020―Jun―25 |
Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2-exploring RAS inhibitors-authors’ reply |
Carlos Taxonera, Iñigo Sagastagoitia, Cristina Alba, Norberto Mañas, David Olivares, Enrique Rey |
| 25 |
[GO] |
2020―May―20 |
Letter: does vitamin D have a potential role against COVID-19? |
Deepak Kumar, Prakamya Gupta, Dibyajyoti Banerjee |
| 26 |
[GO] |
2020―May―14 |
“Review article: COVID-19 and liver disease - what we know on 1st May 2020” |
Isabel Garrido, Rodrigo Liberal, Guilherme Macedo |
| 27 |
[GO] |
2020―May―14 |
Letter: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity |
Jose Mansur |
| 28 |
[GO] |
2020―May―14 |
Letter: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity. Authors' reply |
Jonathan M Rhodes, Sreedhar Subramanian, Eamon Laird, Rose Anne Kenny |
| 29 |
[GO] |
2020―May―14 |
Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic |
Samantha Jane Benson-Pope, Richard B. Gearry |
| 30 |
[GO] |
2020―May―14 |
Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic-authors' reply |
Dominic Stephen King, Nigel John Trudgill, Nicola J. Adderley |
| 31 |
[GO] |
2020―May―14 |
Letter: does vitamin D have a potential role against COVID-19? Authors' reply |
Yuan Tian, Long Rong |
| 32 |
[GO] |
2020―May―06 |
Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2 - exploring RAS inhibitors |
Mayur Garg, Simon G Royce, John S Lubel |
| 33 |
[GO] |
2020―May―02 |
2019 Novel Coronavirus Disease (COVID-19) in patients with Inflammatory Bowel Diseases |
Carlos Taxonera, Iñigo Sagastagoitia, Cristina Alba, Norberto Mañas, David Olivares, Enrique Rey |
| 34 |
[GO] |
2020―Apr―30 |
Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North - supports vitamin D as a factor determining severity. Authors' reply |
Mayur Garg, Aysha Al-Ani, Hannah Mitchell, Philip Hendy, Britt Christensen |
| 35 |
[GO] |
2020―Apr―29 |
Review Article: Prevention, Diagnosis and Management of COVID-19 in the Inflammatory Bowel Disease Patient |
Aysha Al-Ani, Ralley Prentice, Clarissa Rentsch, Doug Johnson, Zaid Ardalan, Neel Heerasing, et al. (+7) Mayur Garg, Sian Campbell, Joe Sasadeusz, Fin Macrae, Siew C. Ng, David T. Rubin, Britt Christensen |
| 36 |
[GO] |
2020―Apr―20 |
Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North - supports vitamin D as a factor determining severity |
Jonathan M Rhodes, Sreedhar Subramanian, Eamon Laird, Rose Anne Kenny |
| 37 |
[GO] |
2020―Apr―14 |
Letter: Covid-19 and vitamin D-authors' reply |
Yuan Tian, Long Rong |
| 38 |
[GO] |
2020―Apr―13 |
Letter: Covid-19, and vitamin D |
Alba Panarese, Endrit Shahini |
| 39 |
[GO] |
2020―Mar―29 |
Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission |
Yuan Tian, Long Rong, Weidong Nian, Yan He |
